ライフサイエンスコーパス: microperfusion

1 examined by confocal microscopy during IBDU microperfusion.

2 re and during application of these agents by microperfusion.

3 or 4 to 13 d before isolation of the CCD for microperfusion.

4 hetized rats previously prepared for in vivo microperfusion.

5 revealed a 49% reduction of kidney allograft microperfusion 2 hr after the intake of CsA, which might

6 l nephron net HCO(3) reabsorption by in vivo microperfusion (37.8 +/- 3.2 versus 16.6 +/- 1.5 pmol/mm

7 ydroxyethyl starches and saline on pulmonary microperfusion and gas exchange during systemic inflamma

8 Ex vivo microperfusion and in vitro experiments with NEFA-bound

9 al tubule function, in vitro proximal tubule microperfusion and in vivo micropuncture measurements we

10 ith limited spatial access, we have designed microperfusion and in-bore oxygenation systems capable o

11 A dual microperfusion apparatus was used to expose guinea-pig o

12 igher distal nephron H+ secretion by in vivo microperfusion as shown previously.

13 nses to AMPA (1 or 5 microM applied by brief microperfusion) as measured using the nystatin patch met

14 The use of the microperfusion chamber has the following major advantage

15 A novel microperfusion chamber was developed to measure kinetic

16 Using the microperfusion chamber, water and dimethylsulfoxide (DMS

17 s the first distinct image with quantitative microperfusion data from gated human foot microvasculatu

18 re whether acute changes of kidney allograft microperfusion due to the administration of cyclosporine

19 Further, microperfusion experiments showed that HOE694-sensitive

20 Stationary in vivo microperfusion experiments showed that luminal perfusion

21 er, REM sleep was not reduced by scopolamine microperfusion in this same region, at a concentration c

22 Yohimbine (an alpha 2 antagonist) microperfusion into the urinary space produced opposite

23 In the present study, during in vivo microperfusion, lanthanum was used as an extracellular m

24 Contrary to the prevailing model, bilateral microperfusion of 8-OH-DPAT into the PPTn (n = 23 rats)

25 Microperfusion of agmatine into renal interstitium and i

26 ithelial NH3 transport, examined by in vitro microperfusion of cortical and outer medullary collectin

27 As measured by in vitro microperfusion of cortical TAL, CaSR inhibitors increase

28 As predicted, combined microperfusion of D-AP5 (glutamate receptor antagonist)

29 In contrast, microperfusion of etomidate (10 and 30 muM) into the ven

30 In SHR on the basal diet, microperfusion of exogenous ANP into the AHA elicited a

31 ter, bile acid, and HCO(3)(-) transport: the microperfusion of intrahepatic bile duct units (IBDUs) i

32 response to different flow rates during the microperfusion of isolated S2 proximal tubules from mous

33 In vitro microperfusion of isolated TAL showed no significant dif

34 Microperfusion of L-arginine (10[-3] M) into the peritub

35 Microperfusion of live renal distal tubules reveals that

36 During in vivo microperfusion of proximal tubules, the extracellular tr

37 In vivo microperfusion of rat distal tubules suggests that a sig

38 y ISS and CSS were therefore recorded during microperfusion of strychnine to block the short latency

39 We test this hypothesis using bilateral microperfusion of the 5-HT(1A) receptor agonist 8-hydrox

40 Microperfusion of the deltaGABAAR-preferring agonist 4,5

41 Microperfusion of urinary space with BU-224 (microM), a

42 s evidence that FET analysis performed under microperfusion opens a brand new alternative for inexpen

43 re applied from micropipettes by brief (1 s) microperfusion pulses.

44 In situ microperfusion revealed that fluid absorptive rate (Jv)

45 Such attributes will ensure the microperfusion rig's continued utility as it may be used

46 d including renal clearance studies, in situ microperfusion, RT-PCR and whole-cell patch clamping.

47 Microperfusion studies demonstrated that transepithelial

48 A voltage-controlled microperfusion system for delivering drugs and simultane

49 A double-barreled microperfusion system was used to apply solutions of wea

50 ated using a development of the single bolus microperfusion technique at chosen flow velocities (U) i

51 ated using a development of the single bolus microperfusion technique at chosen flow velocities in th

52 A novel microperfusion technique was used to identify elevated l

53 With the stationary microperfusion technique, PAH secretion by both normal a

54 mega delta pi were estimated by the red cell microperfusion technique.

55 Net fluid absorption was determined using microperfusion techniques and methoxy[(3)H]inulin with i

56 MTALs from rats were studied by in vitro microperfusion to identify the mechanism underlying cros

57 In contrast, kidney allograft microperfusion was neither significantly reduced in pati

58 -fluid glucose concentrations, and open-flow microperfusion was used to determine the concentrations

59 In vivo luminal microperfusion was used to examine iron transport by the

60 Second, in vivo micropuncture and microperfusion were employed to measure the concentratio